PGR logo

PROGRESSIVE CORP

PGRNYSE
πŸ† #105 by market capEarnings Mar 1 Β· PostUS Equity
$225.66β–² $0.07 (+0.03%)
πŸŒ™ After hours$227.45β–² 0.79%Regular close Β· extended-hours price shown
πŸ””
Track PGR
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.0%
7dβ–² 2.2%
14dβ–² 5.7%
30dβ–² 7.7%
ytdβ–Ό 0.9%
1yβ–² 6.5%
🏦Market Cap
$130.77B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
10.5%
Healthy
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
17.5%
Healthy
βš–οΈP/S Ratio
1.5x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$224.45 – $226.63
52-Week Range
$189.20 – $239.38
Volume (shares)
1,694,237
Avg Volume (shares)
β€”
Shares Outstanding
579.5M
Next Earnings
2027-03-01

Fundamentals Snapshot

Annual Revenue
$87.64B
Last Q Revenue
$23.18B
P/E Ratio
11.4
P/S Ratio
1.5x
EPS (TTM)
$19.93
Dividend Yield
6.12%
Dilution (1yr)
+0.1%
PGR logo

PROGRESSIVE CORP

PGR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$87.6Bβ–² +16.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
29.5%β–² +6.3% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$14.2Bβ–² +32.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$17.2Bβ–² +15.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
588.2Mβ–² +0.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$6.8Bβ–Ό βˆ’$22M YoY
StockOtter Β· stockotter.space

About PROGRESSIVE CORP

The Progressive Corporation, an insurance holding company, offers a comprehensive range of insurance products and associated services across the United States. Its portfolio includes personal and commercial vehicle coverage, residential and commercial property protection, general liability, and various other specialized property-casualty insurance options. The company's operations are structured into three main divisions: Personal Lines, Commercial Lines, and Property. Within the Personal Lines segment, Progressive provides coverage for individual automobiles and recreational vehicles. Offerings range from standard personal auto policies to specialized options for motorcycles, all-terrain vehicles (ATVs), RVs, watercraft, snowmobiles, and similar forms of personal transport. The Commercial Lines division focuses on providing primary liability and physical damage insurance for business vehicles, alongside general liability and property insurance tailored for commercial applications. This segment insures a diverse array of vehicles, including cars, vans, pickup trucks, and dump trucks for small businesses; tractors, trailers, and straight trucks for regional freight, expedited shipping, and long-haul transport companies; heavy-duty vehicles like dump trucks, log trucks, and garbage trucks used in industries such as construction, logging, and mining; and tow trucks and wreckers for towing and service stations, as well as various non-fleet taxis and premium car services. The Property segment offers residential insurance solutions for homeowners, other property owners, and renters. Its portfolio further extends to include personal umbrella policies and both primary and excess flood insurance. Beyond underwriting, the company facilitates policy issuance and claims adjusting. It also serves as an agent for various additional insurance products, such as homeowner general liability and workers' compensation, and provides reinsurance services. Progressive's products are distributed through independent insurance agencies, as well as directly to consumers via its online platforms (including mobile access) and telephone channels. Established in 1937, The Progressive Corporation maintains its headquarters in Mayfield, Ohio.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Hold
31 analysts
Strong Buy3
Buy8
Hold19
Sell1
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

GlobeNewsWireΒ·1d ago

Progressive Announces Investor Relations Call

MAYFIELD VILLAGE, OHIO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- As previously announced, The Progressive Corporation (NYSE: PGR) will host an Investor Relations conference call on Tuesday, November 3, 2026, beginning at 9:30 a

Defense WorldΒ·1d ago

Progressive (NYSE:PGR) Insider Steven Broz Sells 1,225 Shares of Company Stock

The Progressive Corporation (NYSE: PGR - Get Free Report) insider Steven Broz sold 1,225 shares of the firm's stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $223.32, for a t

Business WireΒ·5d ago

TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026

NEW YORK--(BUSINESS WIRE)---- $TGTX--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced initial results from the Company's Phase 1 study evaluating azercabtagene zapreleucel (azer-cel), an investigational, allogeneic

GlobeNewsWireΒ·5d ago

Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026

Single-dose miv-cel continues to demonstrate promising clinical benefit in progressive multiple sclerosis, achieving robust CAR T-cell penetration in the central nervous system (CNS) and improving disability scores while

Business WireΒ·5d ago

Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MSToronto 2026

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CARTCellTherapy--Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients.

Defense WorldΒ·5d ago

The Progressive Corporation $PGR Shares Acquired by Diversify Advisory Services LLC

Diversify Advisory Services LLC lifted its stake in The Progressive Corporation (NYSE: PGR) by 39.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,250